Press Release
Global Neurostimulation Devices Market is Estimated to Reach $10.2 Billion by 2024, Says Variant Market Research
 Published Date:  Aug 2017  Publish By: Variant Market Research

Global Neurostimulation Devices Market Report, published by Variant Market Research, forecast that the global market is expected to reach $10.2 Billion by 2024 from $4 Billion in 2016, growing at a CAGR of 12.7% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 13.8% and 12.9%, respectively, during the forecast period.

"Neurostimulation Devices Market (By Device Type: Implantable Devices and External Devices; By Application: Parkinson’s Disease, Pain Management, Epilepsy, Hearing Loss, Gastroparesis, Urinary And Fecal Incontinence, Depression, And Others; By Geography: North America, Europe, Asia-Pacific and Row) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/medical-devices/neurostimulation-devices-market

The factors driving the growth of the global neurostimulation devices market are rising demand for add-on therapies, high demand from healthcare institutions, rise in number of neurological diseases, and availability of advanced products. Though, high cost of treatments may restrain the market growth. Furthermore, increasing R&D budgets and technological advancements may provide growth opportunities for the market, during the forecast period.

The global neurostimulation devices market has been segmented as device type, application, and geography. Device type is bifurcated into implantable devices (cochlear implants, deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation, gastric electric stimulation, and others) and external devices (transcranial magnetic stimulation (TMS), transcutaneous electrical nerve stimulation (TENS), and others). By application, the segmentations are parkinson’s disease, pain management, epilepsy, hearing loss, gastroparesis, urinary and fecal incontinence, depression, and others. Among the device types, implantable devices accounted for majority of the segment share in 2016. By application, pain management held the largest share in the market and is anticipated to dominated with fastest CAGR during the forecast period 2016 to 2024.

Geographically, the neurostimulation devices market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted for the largest share with 45% of the total market in 2016, driven by high healthcare spending and commercialization of advanced technologies. Europe accounted the second largest market share of 28% in 2016. In terms of growth, Asia-Pacific is expected to grow with the fastest CAGR, driven by growing healthcare facilities, and increasing consumer knowledge and awareness.

The major players in the market include DePuy Synthes Companies, Cyberonics, Inc., Nevro Corporation, St. Jude Medical, Inc., BioControl Medical, Synapse Biomedical, Inc., Neuropace, Inc., Boston Scientific Corporation, NDI Medical, LLC, and NeuroSigma, Inc., among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Neurostimulation Devices Market by Device Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Implantable Devices
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
          4.2.3 Cochlear Implants
          4.2.4 Cochlear Implants
          4.2.5 Deep Brain Stimulation
          4.2.6 Spinal Cord Stimulation
          4.2.7 Vagus Nerve Stimulation
          4.2.8 Gastric Electric Stimulation
          4.2.9 Others
    4.3 External Devices
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
          4.3.3 Transcranial Magnetic Stimulation (TMS)
          4.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
          4.3.5 Others
Chapter 5 Neurostimulation Devices Market by Application: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Parkinson’s Disease
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Pain Management
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Epilepsy
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
    5.5 Hearing Loss
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
    5.6 Gastroparesis
          5.6.1 Current Trend and Analysis
          5.6.2 Market Size and Forecast
    5.7 Urinary and Fecal Incontinence
          5.7.1 Current Trend and Analysis
          5.7.2 Market Size and Forecast
    5.8 Depression
          5.8.1 Current Trend and Analysis
          5.8.2 Market Size and Forecast
    5.9 Others
          5.9.1 Current Trend and Analysis
          5.9.2 Market Size and Forecast
Chapter 6 Neurostimulation Devices Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 France
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 Others
                   6.3.6.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 Others
                   6.4.6.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 DePuy Synthes Companies
    7.2 Cyberonics, Inc.
    7.3 Nevro Corporation
    7.4 St. Jude Medical, Inc.
    7.5 BioControl Medical
    7.6 Synapse Biomedical, Inc.
    7.7 Neuropace, Inc.
    7.8 Boston Scientific Corporation
    7.9 NDI Medical, LLC
    7.10 NeuroSigma, Inc.

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha